MedTrace Logo

The Incidence of Glistenings in the 2017 Intraocular Lenses Made by Alcon and Abbott Medical Optics

NCT03409185 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2023-12-08

No results posted yet for this study

Summary

The purpose of this study is to seek academic/non-industry research funding support to independently investigate the incidence and density of lens glistenings in cataract patients who are implanted with the latest generations of intraocular lenses (IOL) manufactured by Alcon and AMO Medical Optics.

Conditions

  • Cataracts
  • Visual Acuity Reduced Transiently
  • Loss of Visual Contrast Sensitivity
  • Functional Visual Loss

Interventions

DEVICE

Alcon 1 piece SA60AT lens

Optic Diameter: 6.0 mm, Overall length: 13.0 mm, Material: Ultraviolet-absorbing Acrylate/Methacrylate Copolymer

DEVICE

AMO 1-piece AABOO lens

Optic Diameter: 6.0 mm, Overall length: 13.0 mm, Material: Ultraviolet-blocking hydrophobic acrylic

Sponsors & Collaborators

  • Kensington Eye Institute

    collaborator OTHER

  • University of Toronto

    lead OTHER

Principal Investigators

  • Sherif El-Defrawy, MD, FRCSC · University of Toronto

  • Yaping Jin, MD, PhD · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-11
Primary Completion
2023-03-31
Completion
2023-03-31
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03409185 on ClinicalTrials.gov